logo
Twitter
Discord
Email
logo
logo
COMPASS Pathways plcNASDAQ - CMPS
Reports
Search reports
Name
Reporting Date
Filing Date
2024-09-30 10-Q2024-09-302024-10-31
2024-06-30 10-Q2024-06-302024-08-01
2024-03-31 10-Q2024-03-312024-05-08
2023-12-31 10-K2023-12-312024-02-29
2023-09-30 10-Q2023-09-302023-11-02
2023-06-30 10-Q2023-06-302023-08-03
2023-03-31 10-Q2023-03-312023-05-11
2022-12-31 10-K2022-12-312023-02-28
2022-09-30 10-Q2022-09-302022-11-03
2022-06-30 10-Q2022-06-302022-08-04
2022-03-31 10-Q2022-03-312022-05-10
2021-12-31 10-K2021-12-312022-02-24
2020-12-31 20-F2020-12-312021-03-09
1
20 / page
About
Name
COMPASS Pathways plc
Overview
COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.
Show More
CEO
Mr. Kabir Kumar Nath M.A., M.B.A.
Industry
Medical Care Facilities
Exchange
NASDAQ
Listing Date
2020-09-18
Address
33 Broadwick Street, London, W1F 0DQ, United Kingdom
Tel
44-71-6676-6461
Website
https://compasspathways.com